Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;33(3):273-278.
doi: 10.1097/QCO.0000000000000647.

Central nervous system infections produced by varicella zoster virus

Affiliations
Review

Central nervous system infections produced by varicella zoster virus

Maria A Nagel et al. Curr Opin Infect Dis. 2020 Jun.

Abstract

Purpose of review: Varicella zoster virus (VZV) causes varicella, establishes latency, then reactivates to produce herpes zoster. VZV reactivation can also cause central nervous system (CNS) disease with or without rash. Herein, we review these CNS diseases, pathogenesis, diagnosis, and treatment.

Recent findings: The most common CNS manifestation of VZV infection is vasculopathy that presents as headache, cognitive decline, and/or focal neurological deficits. VZV vasculopathy has also been associated with cerebral amyloid angiopathy and moyamoya syndrome. Rarely, VZV will produce a meningitis, encephalitis, cerebellitis, and myelopathy. Pathogenic mechanisms include direct VZV infection of affected tissue, persistent inflammation, and/or virus-induced hypercoagulability. Diagnosis is confirmed by the temporal association of rash to disease onset, intrathecal synthesis of anti-VZV antibodies, and/or the presence of VZV DNA in CSF. Most cases respond to intravenous acyclovir with corticosteroids.

Summary: VZV produces a wide spectrum of CNS disorders that may be missed as some cases do not have an associated rash or a CSF pleocytosis. Clinicians must be vigilant in including VZV in their differential diagnosis of CNS infections as VZV is a ubiquitous pathogen; importantly, VZV CNS infections are treatable with intravenous acyclovir therapy and corticosteroids.

PubMed Disclaimer

References

    1. Mahalingam R, Wellish M, Wolf W, et al. Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990; 323:627–631.
    1. Kennedy PG, Grinfeld E, Gow JW. Latent varicella-zoster virus in human dorsal root ganglia. Virology 1999; 258:451–454.
    1. Richter ER, Dias JK, Gilbert JE 2nd, Atherton SS. Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck. J Infect Dis 2009; 200:1901–1906.
    1. Badani H, White T, Schulick N, et al. Frequency of varicella zoster virus DNA in human adrenal glands. J Neurovirol 2016; 22:400–402.
    1. Gershon M, Gershon A. Varicella-zoster virus and the enteric nervous system. J Infect Dis 2018; 218: (Suppl 2): S113–S119.

Publication types

MeSH terms